Hoang-Yen Tran, D <br/><br/>
Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor.  [electronic resource] 

 -  International journal of obesity (2005)  09 2016 
 - 1424-34 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5497 
<br/><br/><label>Standard No.: </label>10.1038/ijo.2016.90  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3T3-L1 Cells<br/>Adipocytes--cytology<br/>Animals<br/>Antimicrobial Cationic Peptides--pharmacology<br/>CD36 Antigens--biosynthesis<br/>Cell Differentiation--drug effects<br/>Diabetes Mellitus, Experimental<br/>Diet, High-Fat--adverse effects<br/>Disease Models, Animal<br/>Fatty Liver--complications<br/>Gene Expression Regulation--drug effects<br/>Hepatocytes--drug effects<br/>Humans<br/>Immunohistochemistry<br/>Lipid Metabolism--drug effects<br/>Liver--pathology<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Obesity--complications<br/>Prediabetic State--complications<br/>Cathelicidins